Advances in Dendritic Systems and Dendronized Nanoparticles: Paradigm Shifts in Cancer Targeted Therapy and Diagnostics
- PMID: 39707984
- DOI: 10.1021/acs.molpharmaceut.4c00856
Advances in Dendritic Systems and Dendronized Nanoparticles: Paradigm Shifts in Cancer Targeted Therapy and Diagnostics
Abstract
Cancer has emerged as a global health crisis, claiming millions of lives annually. Dendrimers and dendronized nanoparticles, a novel class of nanoscale molecules with highly branched three-dimensional macromolecular structures, have gained significant attention in cancer treatment and diagnosis due to their unique properties. These dendritic macromolecules offer a precisely controlled branching architecture, enabling functionalization with specific targeting molecules to enhance the selective delivery of therapeutic agents to tumor cells while minimizing systemic toxicity. Through surface modifications and the incorporation of various components, dendrimers demonstrate remarkable adaptability as nanocarriers for biomedical imaging and theranostic applications. Surface functionalization strategies, including PEGylation and ligand attachment (e.g., folic acid, RGD peptide, lactobionic acid), further enhance biocompatibility and facilitate targeted tumor cell imaging. Leveraging their improved biocompatibility and target specificity, dendritic nanosystems offer heightened sensitivity and precision in cancer diagnostics. Notably, the encapsulation of metal nanoparticles within dendrimers, such as gold nanoparticles, has shown promise in enhancing tumor imaging capabilities. Ongoing advancements in nanotechnology are poised to increase the sophistication and complexity of dendrimer-based systems, highlighting their potential as nanocarriers in drug delivery platforms, with a growing number of clinical trials on the horizon. This review provides a comprehensive overview of the potential and future prospects of dendrimers and dendrimer-based nanocarriers in targeted cancer therapy and diagnosis, exploring their ability to enhance biocompatibility, reduce toxicity, and improve therapeutic outcomes across various malignancies.
Keywords: cancer imaging; cancer targeting; dendrimers; dendronized nanoparticles; nanotechnology; theranostic applications.
Similar articles
-
Dendronized Systems for the Delivery of Chemotherapeutics.Adv Cancer Res. 2018;139:85-120. doi: 10.1016/bs.acr.2018.04.003. Epub 2018 May 18. Adv Cancer Res. 2018. PMID: 29941108 Review.
-
Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.J Drug Target. 2015;23(7-8):642-50. doi: 10.3109/1061186X.2015.1052077. J Drug Target. 2015. PMID: 26453160 Free PMC article. Review.
-
Dendrimer nanoparticles for colorectal cancer applications.J Mater Chem B. 2020 Feb 14;8(6):1128-1138. doi: 10.1039/c9tb02289a. Epub 2020 Jan 23. J Mater Chem B. 2020. PMID: 31971528 Review.
-
Gelatin nanocarriers in oncology: A biocompatible strategy for targeted drug delivery.Int J Biol Macromol. 2025 May;310(Pt 1):143244. doi: 10.1016/j.ijbiomac.2025.143244. Epub 2025 Apr 17. Int J Biol Macromol. 2025. PMID: 40250682 Review.
-
Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.Curr Drug Targets. 2020;21(6):528-540. doi: 10.2174/1389450120666191031092259. Curr Drug Targets. 2020. PMID: 31670619 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical